Literature DB >> 26013984

Hospital-level resource use by the oldest-old for pancreaticoduodenectomy at high-volume hospitals.

Russell C Langan1, Chaoyi Zheng1, Katherine Harris2, Richard Verstraete3, Waddah B Al-Refaie4, Lynt B Johnson5.   

Abstract

INTRODUCTION: Owing to limited data on hospital resources consumed in caring for the oldest-old, we examined the use of pancreaticoduodenectomy (PD)-relevant hospital resources in patients of increasing age treated in high-volume hospitals participating in the University HealthSystem Consortium.
METHODS: Perioperative outcomes, resource use, and direct costs were compared across increasing age groups in 12,766 PDs (<70 years, n = 8,564; 70-79 years, n = 3,302; ≥80 years, n = 900) performed in 79 high-volume hospitals between 2010 and 2014. Linear regression models with and without covariate adjustments were used to assess the impact of older age.
RESULTS: The oldest-old experienced fewer readmissions and had equivalent intensive care unit use and mortality rates compared with both younger cohorts. However, those ≥80 years experienced more complications, blood transfusions, greater total parenteral nutrition (TPN) use, longer duration of stay, and higher direct hospital costs compared with those <70 years No differences were found between patients ≥80 years and those 70-79 years with respect to the administration of blood products, TPN, or the direct cost of PD.
CONCLUSION: Our findings suggest the ability to deliver quality pancreatic surgical care to an aging population without strong associations to increased resource utilization. As the number of octogenarians undergoing PD continues to grow, the impact of this technically complex procedure on other important cancer care metrics, including patient-reported outcomes and quality of life, requires further assessment.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26013984      PMCID: PMC5221761          DOI: 10.1016/j.surg.2015.02.022

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  23 in total

1.  Comparison of outcomes and costs between laparoscopic distal pancreatectomy and open resection at a single center.

Authors:  Adrian M Fox; Kristen Pitzul; Faizal Bhojani; Max Kaplan; Carol-Anne Moulton; Alice C Wei; Ian McGilvray; Sean Cleary; Allan Okrainec
Journal:  Surg Endosc       Date:  2011-12-17       Impact factor: 4.584

2.  A prospective cost analysis of pancreatoduodenectomy.

Authors:  R F Holbrook; K Hargrave; L W Traverso
Journal:  Am J Surg       Date:  1996-05       Impact factor: 2.565

3.  Pancreatic resection for pancreatic cancer.

Authors:  Jeannine Bachmann; Christoph W Michalski; Marc E Martignoni; Markus W Büchler; Helmut Friess
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

4.  Initiation of a critical pathway for pancreaticoduodenectomy at an academic institution--the first step in multidisciplinary team building.

Authors:  Eugene P Kennedy; Ernest L Rosato; Patricia K Sauter; Laura M Rosenberg; Cataldo Doria; Ignazio R Marino; Karen A Chojnacki; Adam C Berger; Charles J Yeo
Journal:  J Am Coll Surg       Date:  2007-05       Impact factor: 6.113

5.  Relationship between hospital volume, system clinical resources, and mortality in pancreatic resection.

Authors:  Bellal Joseph; John M Morton; Tina Hernandez-Boussard; Ilan Rubinfeld; Chadi Faraj; Vic Velanovich
Journal:  J Am Coll Surg       Date:  2009-04       Impact factor: 6.113

6.  Pancreaticoduodenectomy can be safely performed in the elderly.

Authors:  Shuji Suzuki; Satoshi Kaji; Nobusada Koike; Nobuhiko Harada; Mamoru Suzuki
Journal:  Surg Today       Date:  2012-10-27       Impact factor: 2.549

7.  Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy.

Authors:  G A Porter; P W Pisters; C Mansyur; A Bisanz; K Reyna; P Stanford; J E Lee; D B Evans
Journal:  Ann Surg Oncol       Date:  2000-08       Impact factor: 5.344

8.  Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up.

Authors:  Taylor S Riall; John L Cameron; Keith D Lillemoe; Jordan M Winter; Kurtis A Campbell; Ralph H Hruban; David Chang; Charles J Yeo
Journal:  Surgery       Date:  2006-08-28       Impact factor: 3.982

9.  Pancreaticoduodenectomy in elderly adults: is it justified in terms of mortality, long-term morbidity, and quality of life?

Authors:  Fabian Gerstenhaber; Julie Grossman; Nir Lubezky; Eran Itzkowitz; Ido Nachmany; Ronen Sever; Menahem Ben-Haim; Richard Nakache; Joseph M Klausner; Guy Lahat
Journal:  J Am Geriatr Soc       Date:  2013-07-18       Impact factor: 5.562

10.  Hospital cost-categories of pancreaticoduodenectomy.

Authors:  B Topal; G Peeters; H Vandeweyer; R Aerts; F Penninckx
Journal:  Acta Chir Belg       Date:  2007 Jul-Aug       Impact factor: 1.090

View more
  4 in total

1.  Delayed gastric emptying following pancreatoduodenectomy with alimentary reconstruction according to Roux-en-Y or Billroth-II.

Authors:  Tim R Glowka; Markus Webler; Hanno Matthaei; Nico Schäfer; Volker Schmitz; Jörg C Kalff; Jens Standop; Steffen Manekeller
Journal:  BMC Surg       Date:  2017-03-20       Impact factor: 2.102

2.  Indications for pancreaticoduodenectomy affected postoperative outcomes in octogenarians.

Authors:  Takehiro Okabayashi; Kenta Sui; Takahiro Murokawa; Jiro Kimura; Jun Iwata; Sojiro Morita; Tatsuo Iiyama; Yasuhiro Shimada
Journal:  Ann Gastroenterol Surg       Date:  2020-08-31

3.  Pancreaticoduodenectomy as a feasible choice for periampullary malignancy in octogenarians.

Authors:  Stavros Parasyris; Ioannis Hatzaras; Vasiliki Ntella; Theodoros Sidiropoulos; Ioannis Margaris; Nikos Pantazis; Panagiotis Kokoropoulos; Panteleimon Vassiliu; Paraskevi Matsota; Vasileios Smyrniotis; Nikolaos Arkadopoulos
Journal:  Mol Clin Oncol       Date:  2022-08-17

4.  Adjusted Age-Adjusted Charlson Comorbidity Index Score as a Risk Measure of Perioperative Mortality before Cancer Surgery.

Authors:  Chun-Ming Chang; Wen-Yao Yin; Chang-Kao Wei; Chin-Chia Wu; Yu-Chieh Su; Chia-Hui Yu; Ching-Chih Lee
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.